BiomX Statistics
Share Statistics
BiomX has 18.18M shares outstanding. The number of shares has increased by -60.53% in one year.
| Shares Outstanding | 18.18M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.57% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 11.31M |
| Failed to Deliver (FTD) Shares | 11.64K |
| FTD / Avg. Volume | 10.44% |
Short Selling Information
The latest short interest is 23.03K, so 0.13% of the outstanding shares have been sold short.
| Short Interest | 23.03K |
| Short % of Shares Out | 0.13% |
| Short % of Float | 0.2% |
| Short Ratio (days to cover) | 0.74 |
Valuation Ratios
The PE ratio is -0.55 and the forward PE ratio is null.
| PE Ratio | -0.55 |
| Forward PE | null |
| PS Ratio | -40.26 |
| Forward PS | 0.6 |
| PB Ratio | 4.66 |
| P/FCF Ratio | -0.67 |
| PEG Ratio | n/a |
Enterprise Valuation
BiomX Inc. has an Enterprise Value (EV) of 13.60M.
| EV / Earnings | -0.52 |
| EV / Sales | -38.1 |
| EV / EBITDA | -0.6 |
| EV / EBIT | -0.49 |
| EV / FCF | -0.64 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 3.63.
| Current Ratio | 1.58 |
| Quick Ratio | 1.58 |
| Debt / Equity | 3.63 |
| Total Debt / Capitalization | 78.41 |
| Cash Flow / Debt | -1.9 |
| Interest Coverage | -11.52 |
Financial Efficiency
Return on equity (ROE) is -8.49% and return on capital (ROIC) is -152.48%.
| Return on Equity (ROE) | -8.49% |
| Return on Assets (ROA) | -1.05% |
| Return on Capital (ROIC) | -152.48% |
| Revenue Per Employee | -6.16K |
| Profits Per Employee | -451.19K |
| Employee Count | 58 |
| Asset Turnover | -0.01 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 23.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -68.28% in the last 52 weeks. The beta is 1.32, so BiomX 's price volatility has been higher than the market average.
| Beta | 1.32 |
| 52-Week Price Change | -68.28% |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | 2.09 |
| Relative Strength Index (RSI) | 53.78 |
| Average Volume (20 Days) | 111.45K |
Income Statement
In the last 12 months, BiomX had revenue of -357.00K and earned -26.17M in profits. Earnings per share was -5.1.
| Revenue | -357.00K |
| Gross Profit | -1.23M |
| Operating Income | -27.68M |
| Net Income | -26.17M |
| EBITDA | -22.82M |
| EBIT | -27.68M |
| Earnings Per Share (EPS) | -5.1 |
Balance Sheet
The company has 15.86M in cash and 15.09M in debt, giving a net cash position of 772.00K.
| Cash & Cash Equivalents | 15.86M |
| Total Debt | 15.09M |
| Net Cash | 772.00K |
| Retained Earnings | -162.97M |
| Total Assets | 59.98M |
| Working Capital | 19.37M |
Cash Flow
In the last 12 months, operating cash flow was -21.29M and capital expenditures -50.00K, giving a free cash flow of -21.34M.
| Operating Cash Flow | -21.29M |
| Capital Expenditures | -50.00K |
| Free Cash Flow | -21.34M |
| FCF Per Share | -4.16 |
Margins
Gross margin is 343.98%, with operating and profit margins of 7.75K% and 7.33K%.
| Gross Margin | 343.98% |
| Operating Margin | 7.75K% |
| Pretax Margin | 7.32K% |
| Profit Margin | 7.33K% |
| EBITDA Margin | 6.39K% |
| EBIT Margin | 7.75K% |
| FCF Margin | 5.98K% |
Dividends & Yields
PHGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -708.33% |
| FCF Yield | -162.89% |
Analyst Forecast
The average price target for PHGE is $13.5, which is 1775% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.5 |
| Price Target Difference | 1775% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Aug 26, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Aug 26, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -3.42 |
| Piotroski F-Score | 3 |